US Cosmeceuticals Market
US demand to increase 7.2% annually through 2012
Demand for cosmeceutical products is expected to increase 7.2 percent per year to $9.4 billion in 2012, propelled by a stream of new and technologically advanced product introductions offering age-defying and other appearance enhancing benefits for an aging population. The rapid growth of the cosmeceutical market will continue to be based on a combination of science and astute marketing, with evidence regarding product claims far from conclusive in many instances.
Limiting opportunities will be competition from alternative treatments, such as laser resurfacing and cosmetic surgery, which often offer more dramatic results, though at a greater cost in terms of time, money and safety. Cosmeceutical products also face intense pricing competition due to the growing market penetration of private label cosmeceutical brands and the rapid commoditization of innovative ingredients and products.
Skin care products to remain dominant segment
Skin care products will account for over 60 percent of all cosmeceutical product demand in 2012. Anti-aging products will achieve above-average growth, with gains driven by a highly receptive, fastexpanding group of middle-aged and relatively affluent consumers who want to prevent or redress visible damage to the skin caused by aging, ultraviolet radiation and other environmental stressors. Improved formulations will further promote the use of age-defying products.
More Details
Injectable products to see fastest growth
Injectable products are expected to experience the fastest growth among cosmeceutical products, achieving double-digit annual gains through 2012. Strong prospects for these products are the result of growing demand and acceptance on the consumer side and the increasing availability and proficiency of practitioners. The aging of the US population, an increasingly competitive work force and continued exposure to beauty “ideals” in entertainment and advertising are expected to spur continued interest in professional products.
Botulinum toxin, hyaluronic acid among best prospects
Demand for cosmeceutical chemicals will grow as producers increasingly develop more effective, value-added active ingredients to add to their product formulations. Chemicals used in injectable products will drive gains, with strong advances expected for botulinum toxin, the key ingredient in BOTOX; and hyaluronic acid, the substance on which recently introduced dermal fillers RESTYLANE, JUVEDERM and ELEVESS are based. Hyaluronic acid is finding greater use in over-the-counter age-defying products, particularly skin care items.
Other chemicals expected to record rapid gains include amino acids and antioxidants (e.g., vitamins A and C), which are the active ingredients in many anti-aging creams and lotions; botanical extracts, which serve a variety of cosmeceutical functions; and beta hydroxy acids, which have become an important ingredient in various skin care products due to their ability to offer exfoliant and cell renewal properties with less risk of adverse reactions than other chemicals.
Study coverage
This new industry study, Cosmeceuticals, presents historical demand data (1997, 2002, 2007) and forecasts for 2012 and 2017 by product and chemical. The study also considers market environment factors, evaluates company market share and profiles leading competitors.
More info: http://www.reportlinker.com/p097920/US-Cosmeceuticals-Market.html
